Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Market Cap	1.23T +60.4%
Revenue (ttm)	971.25B +4.3%
Net Income	61.59B -11.2%
EPS	2,788.97
Shares Out	22.08M
PE Ratio	20.04
Forward PE	n/a
Dividend	2,500.00 (4.47%)
Ex-Dividend Date	n/a

Volume	100
Average Volume	4,085
Open	55,900
Previous Close	n/a
Day's Range	55,900 - 55,900
52-Week Range	34,100 - 60,500
Beta	-0.19
RSI	53.85
Earnings Date	Jul 17, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I...

• Industry: Pharmaceutical Preparations
• Founded: 2003
• Employees: 469
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: VDP

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.